27 related articles for article (PubMed ID: 1591047)
1. Evidence for aldosterone-dependent growth of renal cell carcinoma.
King S; Bray S; Galbraith S; Christie L; Fleming S
Int J Exp Pathol; 2014 Aug; 95(4):244-50. PubMed ID: 24802662
[TBL] [Abstract][Full Text] [Related]
2. Microvessel density is high in clear-cell renal cell carcinomas of Ukrainian patients exposed to chronic persistent low-dose ionizing radiation after the Chernobyl accident.
Romanenko AM; Ruiz-Saurí A; Morell-Quadreny L; Valencia G; Vozianov AF; Llombart-Bosch A
Virchows Arch; 2012 Jun; 460(6):611-9. PubMed ID: 22581103
[TBL] [Abstract][Full Text] [Related]
3. mTOR inhibitors in advanced renal cell carcinoma.
Voss MH; Molina AM; Motzer RJ
Hematol Oncol Clin North Am; 2011 Aug; 25(4):835-52. PubMed ID: 21763970
[TBL] [Abstract][Full Text] [Related]
4. Proliferative heterogeneity of human renal cell carcinomas and prevalence of ras gene point mutations.
Waldmann V; Rabes HM
J Cancer Res Clin Oncol; 1996; 122(4):207-13. PubMed ID: 8601572
[TBL] [Abstract][Full Text] [Related]
5. Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction.
Suzuki Y; Tamura G; Maesawa C; Fujioka T; Kubo T; Satodate R
Virchows Arch; 1994; 424(5):453-7. PubMed ID: 8032525
[TBL] [Abstract][Full Text] [Related]
6. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
7. Infrequent ras oncogene point mutations in renal cell carcinoma.
Nanus DM; Mentle IR; Motzer RJ; Bander NH; Albino AP
J Urol; 1990 Jan; 143(1):175-8. PubMed ID: 2403598
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the Ki-ras oncogene in endometrial carcinoma.
Ignar-Trowbridge D; Risinger JI; Dent GA; Kohler M; Berchuck A; McLachlan JA; Boyd J
Am J Obstet Gynecol; 1992 Jul; 167(1):227-32. PubMed ID: 1442931
[TBL] [Abstract][Full Text] [Related]
9. Analysis of ras oncogene mutations in human squamous cell carcinoma of the head and neck.
Núñez F; Domínguez O; Coto E; Suárez-Nieto C; Pérez P; López-Larrea C
Surg Oncol; 1992 Dec; 1(6):405-11. PubMed ID: 1341278
[TBL] [Abstract][Full Text] [Related]
10. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
[TBL] [Abstract][Full Text] [Related]
11. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the ras protooncogenes are rare events in renal cell cancer.
Rochlitz CF; Peter S; Willroth G; de Kant E; Lobeck H; Huhn D; Herrmann R
Eur J Cancer; 1992; 28(2-3):333-6. PubMed ID: 1591047
[TBL] [Abstract][Full Text] [Related]
13. [Significance of oncogenes and growth factors in hypernephroma].
Peter S
Urologe A; 1992 Jan; 31(1):24-7. PubMed ID: 1553800
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
